Announcement of Zhejiang Jianfeng Group's subsidiary receiving the approval letter for drug supplemental application
Zhejiang Jianfeng Group: Announcement of Progress in Zhejiang Jianfeng Group's Major Transaction Planning with Tasly Pharmaceutical Group, a subsidiary of Biomedical Industry Group Co., Ltd.
Announcement of Progress in Zhejiang Jianfeng Group's Major Transaction Planning with Tasly Pharmaceutical Group, a subsidiary of Biomedical Industry Group Co., Ltd.
Zhejiang Jianfeng Group's announcement regarding the major events planned by its subsidiary Tasly Pharmaceutical Group in the biomedical industry.
Announcement of Zhejiang Jianfeng Group's subsidiary receiving the approval letter for drug supplemental application
Announcement on the implementation of equity distribution for the year 2023 of Zhejiang Jianfeng Group.
Zhejiang Jianfeng Group's announcement of a decrease in performance for the first half of 2024.
Announcement of Zhejiang Jianfeng Group's subsidiary obtaining pharmaceutical registration certificate.
Announcement of the resolution of the 3rd meeting of the 12th board of directors of Zhejiang Jianfeng Group.
Announcement of Zhejiang Jianfeng Group on Subsidiary's Extension of Loan to External Party
Announcement of Zhejiang Jianfeng Group on the Election of Employee Supervisors.
Announcement of Zhejiang Jianfeng Group's subsidiary obtaining pharmaceutical registration certificate.
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Jianfeng Group
Zhejiang Yijian Law Firm's Legal Opinion on the 2023 Annual General Meeting of Shareholders of Jianfeng Group
Announcement of Jianfeng Group on the subsidiary obtaining a notice of approval for the marketing application of chemical raw materials
Materials of the 2023 Annual General Meeting of Shareholders of Jianfeng Group
Announcement of Jianfeng Group on the subsidiary obtaining a notice of approval for the marketing application of chemical raw materials
Announcement of Jianfeng Group on holding the 2023 Annual Results Briefing
Announcement of Jianfeng Group on the subsidiary obtaining a drug registration certificate
Jianfeng Group's 2023 non-operating capital occupation and other related capital transactions
No Data